Polyaminoacid Based Core@shell Nanocarriers of 5-Fluorouracil: Synthesis, Properties and Theranostics Application

被引:4
作者
Szczech, Marta [1 ]
Hinz, Alicja [2 ]
Lopuszynska, Natalia [3 ]
Bzowska, Monika [2 ]
Weglarz, Wladyslaw P. [3 ]
Szczepanowicz, Krzysztof [1 ]
机构
[1] Polish Acad Sci, Jerzy Haber Inst Catalysis & Surface Chem, PL-30239 Krakow, Poland
[2] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland
[3] Polish Acad Sci, Henryk Niewodniczanski Inst Nucl Phys, PL-31342 Krakow, Poland
关键词
nanocarriers; 5-Fluorouracil; theranostics; drug delivery; anticancer; fluorine magnetic resonance imaging; DRUG-DELIVERY SYSTEMS; POLYMERIC NANOPARTICLES; ENCAPSULATION; NANOCAPSULES; METABOLISM; ACID; 5-FU; MRI;
D O I
10.3390/ijms222312762
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer is one of the most important health problems of our population, and one of the common anticancer treatments is chemotherapy. The disadvantages of chemotherapy are related to the drug's toxic effects, which act on cancer cells and the healthy part of the body. The solution of the problem is drug encapsulation and drug targeting. The present study aimed to develop a novel method of preparing multifunctional 5-Fluorouracil (5-FU) nanocarriers and their in vitro characterization. 5-FU polyaminoacid-based core@shell nanocarriers were formed by encapsulation drug-loaded nanocores with polyaminoacids multilayer shell via layer-by-layer method. The size of prepared nanocarriers ranged between 80-200 nm. Biocompatibility of our nanocarriers as well as activity of the encapsulated drug were confirmed by MTT tests. Moreover, the ability to the real-time observation of developed nanocarriers and drug accumulation inside the target was confirmed by fluorine magnetic resonance imaging (F-19-MRI).
引用
收藏
页数:12
相关论文
共 57 条
  • [1] Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
  • [2] [Anonymous], 2006, BIOL BASIS CANC
  • [3] Novel Strategies to Improve the Anticancer Action of 5-Fluorouracil by Using Drug Delivery Systems
    Arias, Jose L.
    [J]. MOLECULES, 2008, 13 (10): : 2340 - 2369
  • [4] Polyelectrolyte Oil-Core Nanocarriers for Localized and Sustained Delivery of Daunorubicin to Colon Carcinoma MC38 Cells: The Case of Polysaccharide Multilayer Film in Relation to PEG-ylated Shell
    Bazylinska, Urszula
    Pietkiewicz, Jadwiga
    Rossowska, Joanna
    Chodaczek, Grzegorz
    Gamian, Andrzej
    Wilk, Kazimiera A.
    [J]. MACROMOLECULAR BIOSCIENCE, 2017, 17 (05)
  • [5] In vivo drug tracking with 19F MRI at therapeutic dose
    Bo, Shaowei
    Yuan, Yaping
    Chen, Yongping
    Yang, Zhigang
    Chen, Shizhen
    Zhou, Xin
    Jiang, Zhong-Xing
    [J]. CHEMICAL COMMUNICATIONS, 2018, 54 (31) : 3875 - 3878
  • [6] Nanoparticles in cancer therapy and diagnosis
    Brigger, I
    Dubernet, C
    Couvreur, P
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) : 631 - 651
  • [7] Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by F-18 PET and F-19 MRI: A comparative animal study
    Brix, G
    Bellemann, ME
    Haberkorn, U
    Gerlach, L
    Lorenz, WJ
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (07) : 897 - 906
  • [8] SELECTIVE F-19 MR-IMAGING OF 5-FLUOROURACIL AND ALPHA-FLUORO-BETA-ALANINE
    BRIX, G
    BELLEMANN, ME
    ZABEL, HJ
    BACHERT, P
    LORENZ, WJ
    [J]. MAGNETIC RESONANCE IMAGING, 1993, 11 (08) : 1193 - 1201
  • [9] Encapsulation of camptothecin into pegylated polyelectrolyte nanocarriers
    Bzowska, Monika
    Karabasz, Alicja
    Szczepanowicz, Krzysztof
    [J]. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2018, 557 : 36 - 42
  • [10] Therapeutic nanoparticles for drug delivery in cancer
    Cho, Kwangjae
    Wang, Xu
    Nie, Shuming
    Chen, Zhuo
    Shin, Dong M.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (05) : 1310 - 1316